A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2034

Conditions
Health Risk Behaviors
Interventions
DIAGNOSTIC_TEST

Low dose CT

A subject can voluntarily discontinue active screening with LDCTs after the baseline LDCT is completed but will remain in study follow-up with follow-up calls in 12-month intervals for up to 10 years since initial consent

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Sang-Won Um

OTHER